Gå til indhold

MOST A/S † Opløst

2011
Stiftet
0
Ansatte
Seneste nyheder
1. maj 2024
·
proinvestor.com

Stor wegovy stigning i US mens Zepbound falder under gulvet

Most
doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says PUBLISHED WED, APR 17 202411:23 AM EDTUPDATED WED, APR 17 202412:40 PM EDT Most doses of Eli Lilly's highly popular weight loss drug Zepbound and diabetes counterpart Mounjaro will be in short supply through the second quarter of this year due to increased demand, according to an update on the Food and Drug Administration's drug shortage database.
Læs artikel
Hent flere nyheder
Kort fortalt
MOST A/S blev etableret i 2011.
Der er ingen regnskaber at vise for denne virksomhed.